Clincosm LogoSign in Get a demo

GERONTACCESS: Telemedicine and Nursing Home

Sponsor
University Hospital, Limoges (Other)
Overall Status
Completed
CT.gov ID
NCT02816177
Collaborator
(none)
428
Enrollment
1
Location
2
Arms
34.9
Actual Duration (Months)
12.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Telemedicine-based care provides remote health and social care to maintain people's autonomy and increase their quality of life. The rapidly aging population has come with a significant increase in the prevalence of chronic diseases and their effects, and thus the need for increased care and welfare.

This solutions give a new opportunity for diagnosis, treatment, education, and rehabilitation, and make it possible to monitor patients with a number of chronic diseases. It also reduces socioeconomic disparity with regard to access to care and gives equal chances to patients from urban and rural areas.

This a randomized trial of telemedicine versus usual care alone to reduce hospitalization and emergency hospital admissions for Nursing Home Residents .

After an initial assessment , each participant is monitored by teleconsultation on six occasions over 12 months. Patients with usual care have an initial and a 12 months assessments.

Condition or Disease Intervention/Treatment Phase
  • Other: Telemedicine
  • Other: Usual Care
 N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
428 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Impact of Telemedicine on Avoiding Emergency Hospital Admissions and Hospitalization for Nursing Home Residents
Actual Study Start Date :
Jul 5, 2016
Actual Primary Completion Date :
Jan 18, 2018
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telemedicine

Usual care and telemedicine consultations during12 months.

Other: Telemedicine

Other: Usual Care
Active Comparator: Usual care alone

Usual care during12 months.

Other: Usual Care

Outcome Measures

Primary Outcome Measures

  1. Efficacy [12 month]

    Proportion of patients who had an admission to the emergency or unscheduled hospitalization in health service or surgery

Secondary Outcome Measures

  1. MAST [12 months]

    Cost / effectiveness of telemedicine based on the MAST model (Model of Assessment of Telemedicine ).

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

  • Elderly over 60 years

  • Resident in nursing homes

  • Resident with multiples chronic diseases with at least two comorbidities

  • Having given free and informed consent in writing and signed by himself and / or his legal representative

Exclusion Criteria:

  • Resident unaffiliated or not beneficiary of Social Security

  • Resident with a life-threatening disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Service de Gériatrie Limoges France

Sponsors and Collaborators

  • University Hospital, Limoges

Investigators

  • Principal Investigator: Thierry DANTOINE, MD, CHU Limoges

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Limoges
ClinicalTrials.gov Identifier:
NCT02816177
Other Study ID Numbers:
  • I14036/GERONTACCESS
First Posted:
Jun 28, 2016
Last Update Posted:
Jul 5, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided

Study Results

No Results Posted as of Jul 5, 2019